Garner Health: $100M Series E Lifts Valuation to $2.74B
Garner Health closed a $100 million Series E led by Index Ventures at a $2.74 billion valuation on May 28, capping a $218 million two-round sprint. The deal underscores how AI-driven provider quality scoring has become the most fundable category in employer health tech.
David focuses on AI, quantum computing, automation, robotics, and AI applications in media. Expert in next-generation computing technologies.
LONDON, Monday, June 8, 2026 — Garner Health closed a $100 million Series E at a $2.74 billion valuation, the New York-based employer healthcare startup said, capping a $218 million fundraising sprint over three months. Index Ventures led the round on May 28, 2026, with participation from existing backers Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund, and Kaiser Permanente Ventures, bringing the valuation to $2.74 billion. The deal comes three months after a $118 million Series D in February. Garner has now raised roughly $300 million in total. Founder and CEO Nick Reber is pitching the company as the AI-driven quality layer that sits between employers, insurers, and physicians.
Key Takeaways
- Garner's Series E at $2.74B values the business at roughly 14x its ~$200M gross ARR, a premium pegged to AI-enabled provider scoring.
- ARR has doubled year-over-year for five consecutive periods, the metric institutional investors are now underwriting against.
- The platform reaches roughly 2.5 million members across nearly 800 clients and claims an average 12% annual reduction in healthcare spend.
- The syndicate — Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund and Kaiser Permanente Ventures — is unusually concentrated for a Series E.
- Capital is earmarked for AI product expansion, including a Research Agent and a member-facing Assistant.
Context & Analysis
The round lands in a digital health market sorting hard winners from also-rans. Digital health startups pocketed $4 billion in venture capital in Q1 2026, $1 billion above the same quarter last year and the strongest first quarter since the pandemic peak. Just 12 companies captured 59% of total quarterly funding through deals of $100 million or more. Garner is now the second consecutive quarter where it has cleared that bar.
The differentiator is data scale. Garner parses 60 billion medical records across 320 million patients, evaluating providers using 550 proprietary clinical metrics, and routes roughly 2.5 million members to high-performing providers while delivering an average 12% reduction in total healthcare spend for enterprise employers in the first year. Customers include USA Today, Paylocity, and the University of Oklahoma, with Archer-Daniels-Midland and its 44,000 employees recently signed.
For deeper context, see our related analysis: "Why Healthcare Organizations Are Accelerating Digital Platform Adoption in 2026, Led by Epic, Cerner".
Recent Deal Activity
| Company | Position | Recent Move | Source |
|---|---|---|---|
| Garner Health | Provider quality / care navigation | $100M Series E at $2.74B valuation (May 28, 2026) | PR Newswire |
| Whoop | Consumer health wearable | $575M Series G at $10.1B valuation | Bloomberg |
| OpenEvidence | Clinical AI search | $250M Series D | Fierce Healthcare |
| Verily | Precision health (Alphabet) | $300M raise | MedCity News |
Competitive Landscape
Care navigation is now a contested category. Garner sells employers a quality-and-incentive layer; Whoop and Oura sell consumers continuous biometrics; OpenEvidence sells clinicians an AI-native search tool. The categories are bleeding into each other.
Related: AWS, Google Cloud, Microsoft Compete for Health Tech Workloads
Whoop's $575 million Series G marked the biggest deal of Q1, followed by Verily ($300 million), OpenEvidence ($250 million), Talkiatry ($210 million), eMed ($200 million) and Grow Therapy ($150 million). Whoop's round, at a $10.1 billion valuation, was led by Collaborative Fund and included 2PointZero Group, the Qatar Investment Authority, Mubadala, Abbott and Mayo Clinic. Rock Health stopped differentiating between AI and non-AI startups in Q1 because essentially every digital health startup is now AI-enabled.
Related: Whoop Expands Beyond Athletes, Targets Mainstream Health Market in 2026
For deeper context, see our Health Tech analysis: "Microsoft, Google, Oracle Strengthen Health Tech Interoperability".
Funding Comparables
| Company | Category | Key Development | Impact |
|---|---|---|---|
| Garner Health | Employer care navigation | $100M Series E, $2.74B valuation | Validates AI provider-scoring thesis |
| Whoop | Wearable/biometrics | $575M Series G, $10.1B valuation | Sets IPO benchmark for consumer health |
| OpenEvidence | Clinical AI search | $250M Series D | EHR-embedded AI as enterprise wedge |
| Talkiatry | Telepsychiatry | $210M Series D | In-network behavioral health scales |
| Midi Health | Women's health | $100M, unicorn status | Specialty virtual care endures |
What It Means
For Enterprise Buyers
HR and benefits leaders now have a third procurement category — provider intelligence — alongside PBMs and point solutions. Garner says employers using the platform see an average 12% reduction in healthcare spend during the first year. The model drives 46% of eligible members to actively utilize the system, a usage rate that out-paces most point solutions. The pitch is cost containment without network disruption.
For Investors
2026 has continued a trend of "haves and have-nots" in digital health funding, where some startups attract large rounds while others struggle to raise. Garner's 14x ARR multiple sits well below frontier AI valuations but above traditional health services comps — the sweet spot venture capital is willing to underwrite. Companies with FDA clearances, HIPAA-compliant infrastructure, and existing payer contracts are worth materially more than companies with "AI-enabled" in their pitch deck and no path to reimbursement.
Additional coverage: Why Health Tech Is Core in 2026, Led by Abbott and Gartner
Additional coverage: How Health Tech Is Integrating AI With EHRs in 2026, According to Epic Systems, Snowflake and Forrester
Forward Outlook
Watch three milestones. First, deployment of the Garner Research Agent and member-facing Assistant — both powered by the 60-billion-record claims database and 550 proprietary clinical metrics. Second, a second tender offer for employees signals the company is preparing — but not committing to — a public listing. Third, watch whether Kaiser Permanente Ventures' repeat backing converts to a clinical partnership. If the pace of mega-deals continues, 2026 would end with 50 rounds worth $100 million or more, according to Rock Health.
Related: Microsoft, Google, Epic Advance AI Health Tech Integration Strategies
Related: Microsoft, Google, Epic Advance AI Health Tech Integration Strategies
Additional coverage: Siemens Healthineers and GE HealthCare Advance AI Imaging Adoption
For deeper context, see our Aviation analysis: "Global Aviation Outlook 2026: Enterprise Adoption Accelerates".
For deeper context, see our related analysis: "Consumers Pivot to Prescription Platforms as GLP-1 Demand Reshapes Health Tech Spend".
Sources include company disclosures, regulatory filings, analyst reports, and industry briefings.
Related Coverage
About the Author
David Kim
AI & Quantum Computing Editor
David focuses on AI, quantum computing, automation, robotics, and AI applications in media. Expert in next-generation computing technologies.
Frequently Asked Questions
How much did Garner Health raise in its Series E?
Garner Health raised $100 million in a Series E round at a $2.74 billion valuation, announced on May 28, 2026. Index Ventures led, with participation from Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund, and Kaiser Permanente Ventures.
What does Garner Health actually do?
Garner is an employer-focused care navigation platform. It analyzes a database of over 60 billion medical records covering 320 million patients to score physicians on clinical quality, then uses employer-funded financial incentives to steer members toward those high-performing providers.
How big is Garner's customer base?
Garner reports nearly 800 employer and partner clients reaching about 2.5 million members. Customers include USA Today, Paylocity, the University of Oklahoma, and Archer-Daniels-Midland.
What results does Garner claim?
The company says employers using the platform see an average 12% reduction in healthcare spend in the first year, and that approximately 46% of eligible members actively use the system.
Is an IPO planned?
Garner has not announced an IPO date, but it ran a second employee tender offer alongside the Series E — a step companies typically take to provide liquidity ahead of a possible listing.
